This paper presents a new strategy for the treatment of neurodegenerative diseases such as Alzheimer’s, Parkinson’s, and ALS. The authors discuss how cell- or exosome-based therapies can target the underlying biological processes that drive these conditions.

For patients and families facing neurodegenerative diagnoses, this article offers context on the future of regenerative neurological care.

This is a research reference from our clinical library. Approved by the Chambers Clinic Team — last reviewed May 28, 2026.